Experimental COVID-19 vaccine shows promise in early-stage study

Reuters |
Published: 05.18.20 , 14:49
Moderna Inc said on Monday its experimental vaccine for COVID-19 showed promise in early trials and it looks to advance the vaccine into late-stage trials in July.
The vaccine, mRNA-1273, was also found to be generally safe and well-tolerated in the early-stage study, the drug developer said.